Logo image of ARE-DB-C.CA

AECON GROUP INC (ARE-DB-C.CA) Stock Price, Quote, News and Overview

TSX:ARE-DB-C - Toronto Stock Exchange - - Currency: CAD

99.75  -0.05 (-0.05%)

No Fundamental Analysis report for ARE-DB-C.CA not available.

AECON GROUP INC

TSX:ARE-DB-C (12/27/2023, 7:00:00 PM)

99.75

-0.05 (-0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP26.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)239.12%
Min EPS beat(2)230.76%
Max EPS beat(2)247.49%
EPS beat(4)4
Avg EPS beat(4)134.97%
Min EPS beat(4)25.85%
Max EPS beat(4)247.49%
EPS beat(8)6
Avg EPS beat(8)42.06%
EPS beat(12)9
Avg EPS beat(12)38.15%
EPS beat(16)13
Avg EPS beat(16)39.4%
Revenue beat(2)1
Avg Revenue beat(2)-2.04%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)0.42%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-4.5%
Max Revenue beat(4)7.9%
Revenue beat(8)6
Avg Revenue beat(8)5.36%
Revenue beat(12)9
Avg Revenue beat(12)5.41%
Revenue beat(16)12
Avg Revenue beat(16)5.57%
PT rev (1m)-7.02%
PT rev (3m)-13.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.49%
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.84%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 47.05
Fwd PE 119.78
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 5.72
P/tB 6.46
EV/EBITDA 67.75
EPS(TTM)2.12
EY2.13%
EPS(NY)0.83
Fwd EY0.83%
FCF(TTM)-1.96
FCFYN/A
OCF(TTM)-1.42
OCFYN/A
SpS77.38
BVpS17.45
TBVpS15.43
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.51%
ROE 15.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.6%
GM 5.36%
FCFM N/A
ROA(3y)1.68%
ROA(5y)1.88%
ROE(3y)6.23%
ROE(5y)6.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.66%
ROCE(5y)5.32%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-17.05%
OM growth 5Y0.48%
PM growth 3Y-32.54%
PM growth 5Y-8.44%
GM growth 3Y-10.64%
GM growth 5Y-7.79%
F-Score4
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA 3.65
Cap/Depr 37.65%
Cap/Sales 0.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.3
Altman-Z 3.81
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)80.96%
Cap/Depr(5y)133.56%
Cap/Sales(3y)1.92%
Cap/Sales(5y)3.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)748%
EPS 3Y-34.71%
EPS 5Y-3.88%
EPS Q2Q%262.22%
EPS Next Y590.04%
EPS Next 2Y61.32%
EPS Next 3Y56.74%
EPS Next 5Y42.95%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y10.72%
Revenue growth 5Y10.85%
Sales Q2Q%-6.13%
Revenue Next Year3.11%
Revenue Next 2Y2%
Revenue Next 3Y2.37%
Revenue Next 5Y1.5%
EBIT growth 1Y-102.69%
EBIT growth 3Y-8.16%
EBIT growth 5Y11.39%
EBIT Next Year57.46%
EBIT Next 3Y47.56%
EBIT Next 5Y32.32%
FCF growth 1Y-762.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-180.23%
OCF growth 3YN/A
OCF growth 5YN/A